Cancer patients may soon have a new avenue for treatment, as researchers in Chhattisgarh have found that a rare rice variety, ‘Sanjeevani,’ could hold the key to fighting cancer. The research team from Indira Gandhi Agricultural University in Raipur has been studying a nearly extinct rice strain from the Bastar region. Their findings suggest that this rice can eliminate cancer cells. Initial tests at the Bhabha Atomic Research Centre have provided encouraging results, and the Central Drug Research Institute has also confirmed the anti-cancer properties of Sanjeevani rice. Human trials are slated to begin in January at the Tata Memorial Cancer Hospital. Sanjeevani rice contains 213 biochemicals, including seven potent compounds that are known for their ability to fight cancer. These compounds are believed to activate Nrf2, a critical antioxidant that shields the body from oxidative damage, which can contribute to cancer. A recommended intake of 10 grams daily, this rice may also bolster the immune system. This is a unique discovery, as Sanjeevani could be the world’s first rice variety with medicinal applications. Researchers believe medicinal use could be possible in the next few years. This builds upon the work of Dr. R.H. Richharia, who had previously attempted to categorize and preserve various rice strains.
Hope for Cancer Patients: Chhattisgarh’s ‘Sanjeevani’ Rice Offers New Treatment Pathway
